Radiofrequency ablation in the management of liver tumours

European Journal of Surgical Oncology

Volumn 29, Issue 1, 2003, Pages 9-16

  Gillams, A R ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OCTREOTIDE; OXALIPLATIN;

ARTIFICIAL EMBOLISM; BILE DUCT OBSTRUCTION; BREAST CANCER; CANCER SURVIVAL; CATHETER ABLATION; COLON INJURY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIGESTIVE SYSTEM INJURY; ELECTRODE; EQUIPMENT DESIGN; GALLBLADDER DISEASE; HEMATOMA; HUMAN; IMAGING; INTERMETHOD COMPARISON; LAPAROSCOPY; LAPAROTOMY; LIVER BLOOD FLOW; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; LIVER VEIN OBSTRUCTION; LIVER VEIN THROMBOSIS; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PLEURA EFFUSION; PNEUMOTHORAX; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THERMAL INJURY; TREATMENT OUTCOME;

EID: 0037312581     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1346     Document Type: Review

References (72)

1. d'Arsonval MA. Action physiologique des courants alternatifs. CR Soc Biol 1891; 43: 283-93.
2. Curley S, Davidson B, Fleming R. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver. Surgical Endoscopy 1997; 11: 729-33.
3. Lorentzen T. A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol 1996; 3: 556-63.
4. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995; 2: 670-4.
5. Miao Y, Ni Y, Yu J, Marchal G. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol 2000; 35: 438-44.
6. Miao Y, Ni Y, Mulier S et al. Ex-vivo experiment on radiofrequency liver ablation with saline infusion through a screw-tip cannulated electrode. J Surg Res 1997; 71: 19-24.
7. Livraghi T, Goldberg N, Monti F et al.. Saline enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202: 205-10.
8. Goldberg SN, Ahmed M, Gazelle GS et al. Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology 2001; 219: 157-65.
9. McGahan JP, Dodd GD. Radiofrequency ablation of the liver. Current status. Am J Roentgenol 2001; 176: 3-16.
10. De Baere T, Denys A, Johns Wood B et al. Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. Am J Roentgenol 2001; 176: 187-92.
11. Gillams AR, Lees WR. Thermal ablation induced changes in hepatic arterial perfusion. Radiology 1999; 213P: 382.
12. Goldberg S, Hahn P, Halpern E, Fogle R, Scott Gazelle G. Radiofrequency tissue ablation: effect of pharmacological modulation of blood flow on coagulation diameter. Radiology 1998; 209: 761-7.
13. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-65.
14. Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, Compton CC, Solbiati L, Gazelle GS. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9: 101-11.
15. de Baere T, Bessoud B, Dromain C et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. Am J Roentgenol 2002; 178: 53-9.
16. Denys A, Portier F, Lamarre A, Wicky S. Hepatic vascular occlusions and radiofrequency liver ablation: from animal experiment to clinical observation? Am J Roentgenol 2001; 177: 1215-16.
17. Lees WR, Schumillian C, Gillams AR. Hypotensive anaesthesia improves the effectiveness of radiofrequency ablation in the liver. Radiology 2000; 217: 228.
18. Solbiati L, Lerace T, Goldberg S et al. Percutaneous US guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202: 195-203.
19. Solbiati L, Goldberg SN, Lerace T et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205: 367-73.
20. Rossi S, Stasi M, Carini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996; 167: 759-68.
21. Lencioni R, Goletti O, Armilotta N et al. Radiofrequency thermal ablation of liver metastases with cooled tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998; 8: 1205-11.
22. Cuschieri A, Bracken J, Boni L. Initial experience with laparoscopic ultrasound-guided radiofrequency thermal abalation of hepatic tumours. Endoscopy 1999; 31: 318-21.
23. Siperstein A, Garland A, Engle K et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumours. Ann Surg Onc 2000; 7: 106-13.
24. Siperstein A, Rogers S, Hansen P, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997; 122: 1147-55.
25. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8.
26. Jiao L, Hansen P, Havlik R et al. Clinical short-term results of radiofrequency ablation in primary or secondary liver tumors. Am J Surg 1999; 177: 303-6.
27. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumours: indications, limitations and complications. Ann Surg Onc 2000; 7: 593-600.
28. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136: 1154-7.
29. Elias D, El Otmany A, Goharin A, Attalah D, de Baere T. Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol 2001; 76: 297-300.
30. Montorsi M, Santambrogio R, Bianchi P et al. Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis: role of the laparoscopic approach. Surg Endosc 2001; 15: 141-5.
31. Podnos YD, Henry G, Ortiz JA, Ji P, Cooke J, Cao S, Imagawa DK. Laparoscopic ultrasound with radiofrequency ablation in cirrhotic patients with hepatocellular carcinoma: technique and technical considerations. Am Surg 2001; 67: 1181-4.
32. Raman SS, Lu DSK, Vodopich DJ, Sayre J, Lassman C. Creation of radiofrequency lesions in a porcine model. Correlation with sonography, CT and histopathology. Am J Roentgenol 2000; 175: 1253-8.
33. Hansen PD, Rogers S, Corless C, Swanstrom L, Siperstein A. Radiofrequency ablation lesions in a pig liver model. J Surg Res 1999; 87: 114-21.
34. Rydzewski B, Dehdashti F, Gordon B et al. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Am J Roentgenol 2002; 178: 353-8.
35. Jarnagin WR, Conlon K, Bodniewicz J et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 2001; 91: 1121-8.
36. Paolucci V, Schaeff B, Schneider M, Gutt C. Tumor seeding following laparoscopy: international survey. World J Surg 1999; 23: 989-95.
37. Scott DJ, Fleming JB, Watumull LM et al. Accuracy and effectiveness of laparoscopic vs. open hepatic RF ablation. Surg Endosc 2001; 15: 135-40.
38. Scudamore CH, Lee SI, Patterson EJ et al. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999; 177: 411-17.
39. Goldberg S, Scott Gazelle G, Compton C, Mueller P, Tanabe K. Treatment of intrahepatic malignancy with radiofrequency ablation. radiologic-pathologic correlation. Cancer 2000; 88: 2452-63.
40. Livraghi T, Goldberg SN, Lazzaroni S et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
41. Livraghi T, Goldberg N, Lazzaroni S et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214: 761-8.
42. Rhim H, Dodd GD. Radiofrequency thermal ablation of liver tumours. J Clin Ultrasound 1999; 27: 221-9.
43. Gillams A, Lees WR. Survival after percutaneous, image guided thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43: 656-61.
44. Gillams A, Lees WR. Image guided ablation of colorectal liver metastases: time for a randomized controlled trial versus hepatic resection. Radiology 1999; 213P: 212.
45. Gillams A. Thermal ablation of liver metastases. Abdominal Imaging 2001; 26: 361-8.
46. Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997; 63: 605-10.
47. Nordlinger B, Guiguet M, Vaillant C et al. Surgical resection of colorectal carcinoma metastases to the liver. Cancer 1996; 77: 1254-62.
48. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: Long term results in 117 patients. Radiology 2001; 221: 159-66.
49. Vogl T, Muller P, Meck M et al. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 1999; 9: 675-84.
50. Clouse ME, Perry L, Stuart K, Tokes KR. Hepatic arterial chemoembolization for metastatic neuroendocrine tumours. Digestion 1994; 55: 92-7.
51. Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, Bilchik AJ. Hepatic cytoreduction followed by a novel long-acting somatostatin analogue: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Surgery 2001; 130: 954-62.
52. Gillams AR, Lees WR. Thermal ablation of neuroendocrine liver metastases. European Radiology 2001; 11: 340.
53. Selzner M, Morse M, Vredenburgh J, Meyers W, Clavien P. Liver metastases from breast cancer: long term survival after curative resection. Surgery 2000; 127: 383-9.
54. Livraghi T, Goldberg N, Solbiati L et al. Percutaneous radiofrequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001; 220: 145-9.
55. Laurent C, Rullier E, Feyler A, Masson B, Saric J. Resection of non-colorectal and non-neuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg 2001; 25: 1532-6.
56. Vogl T, Muller P, Hammerstingl R et al. Malignant liver tumors treated with MR imaging - guided laser-induced thermotherapy: technique and prospective results. Radiology 1995; 196: 257-65.
57. Lees WR, Gillams A. Comparison of the effectiveness of cooled tip radiofrequency and interstitial laser photocoagulation in liver tumour ablation. Radiology 1999; 213P: 122.
58. Bilchik AJ, Wood RF, Allegra D et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. Arch Surg 2000; 135: 657-64.
59. Pearson S, Izzo F, Fleming D et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178: 592-9.
60. Chapman WC, Debelak JP, Wright Pinson C et al. Hepatic cryoblation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000; 231: 752-61.
61. Livraghi T, Bolondi L, Buscarini L et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol 1995; 22: 522-6.
62. Shibata T, Iimuro Y, Yamamoto Y et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-7.
63. Pacella CM, Bizzarri G, Magnolfi F et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma; results in 74 patients. Radiology 2001; 221: 712-20.
64. Pacella CM, Bizzarri G, Cecconi O et al. Hepatocellular carcinoma: long term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219: 669-78.
65. Lencioni R, Cioni D, Donati F, Bartolozzi C. Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology 2001; 48: 8-14.
66. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J Clin Onc 1997; 15: 938-94.
67. Steele G, Ravikumar T. Resection of hepatic metastases from colorectal cancer. Ann Surg 1989; 210: 127-38.
68. Elias D, de Baere T, Smayra T et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 2002; 89: 752-6.
69. Bismuth H, Adam R, Levi F et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-22.
70. Shankar A, Leonard P, Renaut AJ et al. Neodajuvant therapy improves respectability rates for colorectal cancer. Ann R Coll Surg Engl 2001; 83: 85-8.
71. Douillard JY, V303 Study Group. Irintoecan and high dose fluorouracil/leucovroin for metastatic colorectal cancer. Oncology 2000; 14: 51-5.
72. Giacchetti S, Perpoint Bi, Zidani R et al. Phase III multicenter trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol 2000; 18: 136-47.